Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of mirabegron 50 mg in healthy Thai volunteers
TCTR20201019002Completed
- Sponsor
- Unison Laboratories
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of mirabegron in overactive bladder (OAB) (2 arms), sponsored by Unison Laboratories. Primary endpoints: Cmax, AUC0-t and 2 more. Started Jan 2021; status: completed.
02
Drugs
mirabegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on TCTR20201019002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201019002.